HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

por Pernas, Sonia, Tolaney, Sara M.
Publicado 2019

Is there a role for CDK 4/6 inhibitors in breast cancer brain metastases?

por Schlam, Ilana, Tolaney, Sara M.
Publicado 2021

Immunotherapy for the Treatment of Triple-Negative Breast Cancer

por Tolaney, Sara M., Shaw, Lindsay
Publicado 2022

Clinical Development of New Antibody–Drug Conjugates in Breast Cancer: To Infinity and Beyond

por Barroso-Sousa, Romualdo, Tolaney, Sara M.
Publicado 2021

Tumor mutational burden as a predictor of immunotherapy response in breast cancer

por O’Meara, Tess A., Tolaney, Sara M.
Publicado 2021

Overcoming Resistance to HER2-Directed Therapies in Breast Cancer

por Schlam, Ilana, Tarantino, Paolo, Tolaney, Sara M.
Publicado 2022

How I treat HER2-low advanced breast cancer

por Schlam, Ilana, Tolaney, Sara M., Tarantino, Paolo
Publicado 2023

Evidence to date: talazoparib in the treatment of breast cancer

por Exman, Pedro, Barroso-Sousa, Romualdo, Tolaney, Sara M
Publicado 2019

CDK4/6 inhibition in breast cancer: current practice and future directions

por Pernas, Sonia, Tolaney, Sara M., Winer, Eric P., Goel, Shom
Publicado 2018

Tumor Mutational Burden in Breast Cancer: Current Evidence, Challenges, and Opportunities

por Barroso-Sousa, Romualdo, Pacífico, Jana Priscila, Sammons, Sarah, Tolaney, Sara M.
Publicado 2023

Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?

por Weis, Luiza N., Tolaney, Sara M., Barrios, Carlos H., Barroso-Sousa, Romualdo
Publicado 2021

The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer

por Grinshpun, Albert, Tolaney, Sara M., Burstein, Harold J., Jeselsohn, Rinath, Mayer, Erica L.
Publicado 2023

Integration of Physician and Nursing Professional Efforts to Deliver Supportive Scalp Cooling Care to Oncology Patients at Risk for Alopecia

por Peterson, Lindsay L., Lustberg, Maryam, Tolaney, Sara M., Ross, Mikel, Salehi, Elahe, Isakoff, Steven J.
Publicado 2020

Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer

por Mittal, Abhenil, Molto Valiente, Consolacion, Tamimi, Faris, Schlam, Ilana, Sammons, Sarah, Tolaney, Sara M., Tarantino, Paolo
Publicado 2023

Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer

por Tolba, Mai F., Santa-Maria, Cesar A., Albini, Adriana, Chimusa, Emile R., Al-Ramadi, Basel K., Tolaney, Sara M.
Publicado 2021

Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer

por Sammons, Sarah, Elliott, Andrew, Barroso-Sousa, Romualdo, Chumsri, Saranya, Tan, Antoinette R., Sledge, George W., Tolaney, Sara M., Torres, Evanthia T. Roussos
Publicado 2023

Immunotherapy for early triple negative breast cancer: research agenda for the next decade

por Tarantino, Paolo, Corti, Chiara, Schmid, Peter, Cortes, Javier, Mittendorf, Elizabeth A., Rugo, Hope, Tolaney, Sara M., Bianchini, Giampaolo, Andrè, Fabrice, Curigliano, Giuseppe
Publicado 2022

Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer

por Leone, José Pablo, Hassett, Michael J., Leone, Julieta, Tolaney, Sara M., Vallejo, Carlos T., Leone, Bernardo A., Winer, Eric P., Lin, Nancy U.
Publicado 2022

A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer

por Tolaney, Sara M, Jeong, Joon, Guo, Hao, Brock, Jane, Morganstern, Daniel, Come, Steven E, Golshan, Mehra, Bellon, Jennifer, Winer, Eric P, Krop, Ian E
Publicado 2014

Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Advanced Breast Cancer: A Systematic Literature Review

por Cuyún Carter, Gebra, Mohanty, Maitreyee, Stenger, Keri, Morato Guimaraes, Claudia, Singuru, Shivaprasad, Basa, Pradeep, Singh, Sheena, Tongbram, Vanita, Kuemmel, Sherko, Guarneri, Valentina, Tolaney, Sara M
Publicado 2021